Related Experiment Video
Updated: Jan 9, 2026
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Reprogramming the Course of Precancer with Targeted Therapeutic Intervention: Lessons from Interception in Gastric
James R Goldenring1,2,3,4, Eunyoung Choi1,2,3, Sachiyo Nomura5,6,7
1Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract:
Although the majority of gastric cancer research has focused on the treatment of late-stage tumor masses, intervention at precancerous stages represents a far more amenable strategy to achieve long-term prevention of cancer. In contrast with preventative strategies focusing on lifestyle changes and nutritional alterations, few efforts have evaluated the ability to use short-term therapeutic interventions to reverse precancer and thereby reduce risk for developing cancer. The distinct advantage of this approach lies in the recognition that precancerous lesions are far more homogeneous with fewer, if any, driver mutations that can lead to therapy resistance. Our recent studies have demonstrated that a limited 2- to 4-week course of MEK inhibitor in rodent models, and now in a human phase I trial, reduced intestinal metaplasia and increased normal acid-secreting parietal cells in the gastric mucosa. These findings demonstrate the efficacy of targeting the precancerous metaplasia with limited duration treatments that allow recrudescence of normal gastric lineages. Further progress to bring these approaches to clinical utility will require a major change in the outlook of pharmaceutical companies and physicians for initiatives to target precancer.
Insights
Targeting precancerous gastric lesions with short-term MEK inhibitor therapy reversed metaplasia and restored normal cells in preclinical and early human studies, offering a novel cancer prevention strategy.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Gastric cancer research predominantly focuses on late-stage tumors.
- Intervention during precancerous stages offers a more effective cancer prevention strategy.
- Targeting early lesions is advantageous due to their homogeneity and fewer mutations, potentially reducing therapy resistance.
Purpose of the Study:
- To evaluate the efficacy of short-term therapeutic interventions in reversing precancerous gastric lesions.
- To explore the potential of targeting metaplasia to reduce gastric cancer risk.
- To investigate the use of MEK inhibitors for precancer reversal.
Main Methods:
- Administration of a MEK inhibitor for a limited duration (2-4 weeks) in rodent models.
- Conducting a human phase I trial to assess the therapeutic intervention.
- Evaluating changes in gastric mucosa, including intestinal metaplasia and parietal cell populations.
Main Results:
- Short-term MEK inhibitor treatment reduced intestinal metaplasia in rodent models.
- The intervention led to an increase in normal acid-secreting parietal cells in the gastric mucosa.
- Early human trials (Phase I) showed promising results in reversing precancerous changes.
Conclusions:
- Limited-duration MEK inhibitor therapy is effective in targeting precancerous gastric metaplasia.
- This approach promotes the restoration of normal gastric lineages.
- A shift in pharmaceutical and clinical perspectives is needed to advance precancer-targeting initiatives.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease